(Q53112682)

11 May 2018

title

The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort study. (English)

1 reference

11 May 2018

1 reference

William David Foulkes

11

1 reference

11 May 2018

Jan Lubiński

3

Jan Lubinski

1 reference

11 May 2018

12

Susan L Neuhausen

1 reference

11 May 2018

17

Steven A Narod

1 reference

11 May 2018

Jacek Gronwald

4

Jacek Gronwald

1 reference

11 May 2018

Parviz Ghadirian

7

Parviz Ghadirian

1 reference

11 May 2018

Charmaine Kim-Sing

10

Charmaine Kim-Sing

1 reference

11 May 2018

Nadine M Tung

9

Nadine Tung

1 reference

11 May 2018

Leigha Senter

13

Leigha Senter

1 reference

11 May 2018

Pål Møller

6

Pal Moller

1 reference

11 May 2018

Beth Karlan

15

Beth Karlan

1 reference

11 May 2018

Yakir Segev

1

Yakir Segev

1 reference

11 May 2018

Hereditary Breast Cancer Study Group

18

Hereditary Breast Cancer Study Group

1 reference

11 May 2018

author name string

Javaid Iqbal

2

1 reference

11 May 2018

Henry T Lynch

5

1 reference

11 May 2018

Barry Rosen

8

1 reference

11 May 2018

Christian F Singer

14

1 reference

11 May 2018

Sun Ping

16

1 reference

11 May 2018

language of work or name

English

0 references

publication date

3 April 2013

1 reference

11 May 2018

published in

Gynecologic Oncology

1 reference

11 May 2018

volume

130

1 reference

11 May 2018

issue

1

1 reference

11 May 2018

page(s)

127-131

1 reference

11 May 2018

The risk of endometrial cancer in women with BRCA1 and BRCA2 mutations. A prospective study.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

Cancer Incidence in BRCA1 mutation carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

Cancer risks in BRCA2 mutation carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

BRCA1 and BRCA2 mutation analysis of 208 Ashkenazi Jewish women with ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

Risk of Endometrial Carcinoma Associated with BRCA Mutation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: a systematic review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

Relevance of breast cancer hormone receptors and other factors to the efficacy of adjuvant tamoxifen: patient-level meta-analysis of randomised trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

Report of Endometrial Cancer in Australian BRCA1 and BRCA2 mutation-positive Families.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

Tamoxifen and risk of endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

The risk of developing uterine sarcoma after tamoxifen use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

High incidence of BRCA1-2 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

Is Uterine Papillary Serous Adenocarcinoma a Manifestation of the Hereditary Breast–Ovarian Cancer Syndrome?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

BRCA1, TP53, and CHEK2 germline mutations in uterine serous carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

Menopause, hormone replacement therapy and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

Endometrial cancer and hormone-replacement therapy in the Million Women Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

Society of Gynecologic Oncologists Education Committee Statement on Risk Assessment for Inherited Gynecologic Cancer Predispositions☆

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2013.03.027

10.1016/J.YGYNO.2013.03.027

7 January 2021

Identifiers

DOI

1 reference

11 May 2018

1 reference

11 May 2018